Yuanyuan Zhang to Protein Kinase Inhibitors
This is a "connection" page, showing publications Yuanyuan Zhang has written about Protein Kinase Inhibitors.
Connection Strength
0.135
-
Liu B, Ding F, Liu Y, Xiong G, Lin T, He D, Zhang Y, Zhang D, Wei G. Incidence and risk of hypertension associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a comprehensive network meta-analysis of 72 randomized controlled trials involving 30013 patients. Oncotarget. 2016 Oct 11; 7(41):67661-67673.
Score: 0.135